206 related articles for article (PubMed ID: 8005662)
1. Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils.
Gray BH; Haseman JR
Infect Immun; 1994 Jul; 62(7):2732-9. PubMed ID: 8005662
[TBL] [Abstract][Full Text] [Related]
2. B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides.
Gray BH; Haseman JR; Mayo KH
Biochim Biophys Acta; 1995 May; 1244(1):185-90. PubMed ID: 7766657
[TBL] [Abstract][Full Text] [Related]
3. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities.
Mayo KH; Haseman J; Ilyina E; Gray B
Biochim Biophys Acta; 1998 Sep; 1425(1):81-92. PubMed ID: 9813253
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
Ooi CE; Weiss J; Doerfler ME; Elsbach P
J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
6. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
7. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
8. Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa.
Wasiluk KR; Skubitz KM; Gray BH
Infect Immun; 1991 Nov; 59(11):4193-200. PubMed ID: 1937776
[TBL] [Abstract][Full Text] [Related]
9. Design of a potent novel endotoxin antagonist.
Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
[TBL] [Abstract][Full Text] [Related]
10. Design of synthetic bactericidal peptides derived from the bactericidal domain P(18-39) of aprotinin.
Pellegrini A; von Fellenberg R
Biochim Biophys Acta; 1999 Aug; 1433(1-2):122-31. PubMed ID: 10446365
[TBL] [Abstract][Full Text] [Related]
11. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
12. Probing structure-activity relationships in bactericidal peptide betapep-25.
Dings RP; Haseman JR; Mayo KH
Biochem J; 2008 Aug; 414(1):143-50. PubMed ID: 18489259
[TBL] [Abstract][Full Text] [Related]
13. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa variants isolated from patients with cystic fibrosis are killed by a bactericidal protein from human polymorphonuclear leukocytes.
Siefferman CM; Regelmann WE; Gray BH
Infect Immun; 1991 Jun; 59(6):2152-7. PubMed ID: 1903774
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
[TBL] [Abstract][Full Text] [Related]
16. Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes.
Pereira HA; Erdem I; Pohl J; Spitznagel JK
Proc Natl Acad Sci U S A; 1993 May; 90(10):4733-7. PubMed ID: 8506327
[TBL] [Abstract][Full Text] [Related]
17. Structure and functions of endotoxin-binding peptides derived from CAP18.
Hirata M; Zhong J; Wright SC; Larrick JW
Prog Clin Biol Res; 1995; 392():317-26. PubMed ID: 8524937
[TBL] [Abstract][Full Text] [Related]
18. Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity.
Abdolhosseini M; Nandula SR; Song J; Hirt H; Gorr SU
Peptides; 2012 Jun; 35(2):231-8. PubMed ID: 22484285
[TBL] [Abstract][Full Text] [Related]
19. Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin.
Bartlett KH; McCray PB; Thorne PS
Int J Antimicrob Agents; 2004 Jun; 23(6):606-12. PubMed ID: 15194132
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
